We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Ixico Plc | IXI | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 8.125 | 08:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.125 | 8.125 | 8.125 | 8.125 | 8.125 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 13/3/2024 08:41 by chrisdgb Some kind of industry investor would be a nice option, as a result of a contract..? |
Posted at 10/5/2023 09:53 by 40 fathoms Nothing new, drawing down cash reserves, as things currently stand they are confirming they will be unprofitable in 2023 and 2024. They have to start winning large contracts in the next 6 months or they are in real trouble. If they don't I reckon at the end of this year the auditor may make them take an impairment for a good part of the large development costs they are capitalising.If as halfpenny suggests investors are indeed circulating they seem to be doing it without actually buying the shares. Without one or two large contract wins there is the possibility in the not too distant future, that we are going to see 15p or lower, in my opinion. |
Posted at 10/5/2023 08:29 by halfpenny Now IXI have a strong platform with cash in the bank, AI products and a strong order book for 2023 and great outlook for 2024.IXI with strong AI products being released puts them ahead of the market. Investors now circulating IXI at these levels. Future looking great for IXI. |
Posted at 24/4/2023 12:45 by halfpenny IXI now likely being pursued by a couple on investors who missed out on Medica Group Plc today.Investors now circulating IXI at these levels. Only large deals with a share price above 33p can keep them away. Future looking great for IXI. |
Posted at 04/4/2023 09:48 by cliffpeat As referred at post 333Report per website: ""The accurate, consistent, and scalable estimation of cerebellar atrophy would be highly beneficial for clinical trials in multiple system atrophy (MSA)1-3. This work performs validation of a fully automatic volume change workflow in MSA using Jacobian integration from non-linear warp-fields estimated with a convolutional neural network (CNN)-based 3D T1- weighted (T1W) image analysis workflow. The developed framework provides a fully automatic solution for estimating cerebellar volume change with increased sensitivity over comparable methods. Additionally, the framework is flexible and highly scalable, and as such has the potential to be advantageous for future clinical trials" My prompt for GPT3.5: What does [it] mean? GPT output: "This paragraph describes a study aimed at developing and validating a computer-based method for accurately and consistently estimating changes in the size of the cerebellum, a part of the brain, in patients with a neurodegenerative disorder called multiple system atrophy (MSA). The researchers used a convolutional neural network (CNN)-based 3D T1-weighted (T1W) image analysis workflow to estimate cerebellar volume changes over time in MSA patients. They found that this approach was fully automatic and more sensitive than comparable methods. The researchers suggest that this framework has the potential to be beneficial for future clinical trials of MSA treatment." I can understand/appreciat GPT doesn't refer to "Jacobian integration" in its re-write so I asked it what it was, (assuming I was a year 13 student). It answered: "Jacobian integration is a mathematical technique that is used to measure the changes in the shape and size of an object over time. Specifically, it calculates how much a certain point in an object has moved from its original position to its new position, as well as how much the surrounding areas of that point have changed. To help you visualize this, imagine a rubber ball that is being squished and stretched in different directions. If you were to pick a point on the surface of the ball and track how it moves as the ball changes shape, that's essentially what Jacobian integration does. It measures the amount of deformation or stretching that occurs at that point and calculates how much the point has moved in the process. This technique can be used in a variety of applications, such as analysing changes in the brain over time, or tracking the movement of fluids in a system." Now THAT explanation with an analogy is clever and useful. I am posting this because I believe that understanding at least an outline of the company's progress and skillsets is "on topic" for investors. I hope you agree. |
Posted at 08/12/2022 17:04 by cliffpeat CasholaaThis is the link from Investor meet Company tweet: and YouTube: |
Posted at 08/12/2022 16:13 by cliffpeat Watching the interesting FY 2022 company presentation on YouTube "Investor Meet Company" this afternoon when it was suddenly taken down - apparently withdrawn "This video has been removed by the uploader".Does anyone know why? Is the presentation available on any other platform? Was there some "inside" information disclosed? |
Posted at 27/10/2022 01:48 by 40 fathoms Unless they sign some very large contracts, very soon they are going to bleed cash in 2023. Based on the trading update at GBP 8.6 million revenue and GBP 1.5 million they were cashflow negative to the tune of GBP 900k. Revenue for FY 2023 is forecast to fall to 7 million.For what its worth the Chief Commercial Officer hire from 2.5 years ago, Lammert Albers, who was considered an important enough hire to RNS and to roll out on Proactive Investors, quit during the summer. If the boards and senior executive team are not shaken up soon this will be taken out and for a lot less than its intrinsic worth. |
Posted at 26/8/2020 14:45 by deltaham Uptick in share price will be due to RNS at 1.55am today from Ixico on yesterday's Investor presentation"IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that a recording of the online Company presentation, delivered by Giulio Cerroni, Chief Executive Officer, and Grant Nash, Chief Finance Officer, on Tuesday 25 August, surrounding the Company's recent trading update, is now available to watch back on the Investor Meet Company platform. The Q&A has also been published following the meeting. "Investors can sign up to Investor Meet Company for free and add to meet IXICO plc via the following link, which will take you to the recording of the presentation and the Q&A: hxxps://www.investor No new price-sensitive information is disclosed as part of the presentation." |
Posted at 26/8/2020 10:01 by deltaham Just noticed Giulio's interview can be played direct from the Ixico web site. Go to Investors, Investors Info, Investors Videos |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
